March 25, 2017 1:01 AM ET

Biotechnology

Company Overview of Edge Therapeutics, Inc.

Company Overview

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions. Its lead product includes EG-1962, a polymer-based microsphere used for the treatment of aneurysmal subarachnoid hemorrhage. The company is also developing EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding on the surface of the brain. Edge Therapeutics, Inc. was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

300 Connell Drive

Suite 4000

Berkeley Heights, NJ 07922

United States

Founded in 2009

31 Employees

Phone:

800-208-3343

Fax:

908-790-1212

Key Executives for Edge Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 51
Total Annual Compensation: $644.9K
Co-Founder, Chief Scientific Officer and Director
Age: 54
Total Annual Compensation: $477.9K
Chief Medical Officer
Age: 63
Total Annual Compensation: $459.4K
Compensation as of Fiscal Year 2015.

Edge Therapeutics, Inc. Key Developments

Edge Therapeutics, Inc. expected to report Fiscal Year 2016 results on March 24, 2017. This event was calculated by Capital IQ (Created on March 18, 2017).

Edge Therapeutics, Inc. expected to report Fiscal Year 2016 results on March 24, 2017. This event was calculated by Capital IQ (Created on March 18, 2017).

Edge Therapeutics, Inc. Announces Executive Changes, Effective March 10, 2017

Albert N. Marchio II, Chief Accounting and Administrative Officer of Edge Therapeutics, Inc., became Edge’s Chief Financial Officer on an interim basis, effective March 10, 2017. In addition, Andrew J. Einhorn, previously Edge’s Chief Financial Officer, left Edge effective March 10, 2017 to pursue other interests. Mr. Marchio will also continue to serve as Edge’s Chief Accounting and Administrative Officer. Mr. Marchio has served as Edge’s Chief Accounting and Administrative Officer since October 2016 and as Edge’s Chief Accounting and Operations Officer from March 2014 through October 2016. Prior to March 2014, Mr. Marchio served as Edge’s Chief Financial Officer from December 2011 through March 2014.

Edge Therapeutics, Inc. Presents at Cowen and Company 37th Annual Health Care Conference, Mar-08-2017 09:20 AM

Edge Therapeutics, Inc. Presents at Cowen and Company 37th Annual Health Care Conference, Mar-08-2017 09:20 AM. Venue: The Boston Marriott Copley Place, 110 Huntington Avenue, Boston, Massachusetts, United States. Speakers: Brian A. Leuthner, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Edge Therapeutics, Inc., please visit www.edgetherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.